SOPHiA GENETICS Company
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Investors
(Reupload).png)
.jpeg)
.png)
.png)
.png)
.jpg)
.png)
.jpeg)
Technology:
Artificial Intelligence, Big Data, Bioinformatics, Biotechnology, Genetics, Health Care, Life Science, Medical
Industry:
Early Drug Development
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2011-01-01
Employees Number:
251-500
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
19
Total Funding:
250152150
Estimated Revenue:
$50M to $100M
Last Funding Date:
2020-10-01
Last Funding Type:
Series F
Register and Claim Ownership